Pulmonary Arterial Hypertension Stocks List

Recent Signals

Date Stock Signal Type
2020-01-17 ARNA Crossed Above 50 DMA Bullish
2020-01-17 BLPH 50 DMA Support Bullish
2020-01-17 BLPH Spinning Top Other
2020-01-17 EIGR Fell Below 20 DMA Bearish
2020-01-17 GILD Lower Bollinger Band Walk Weakness
2020-01-17 LLY Upper Bollinger Band Walk Strength
2020-01-17 LLY Slingshot Bullish Bullish Swing Setup
2020-01-17 LQDA Upper Bollinger Band Walk Strength
2020-01-17 LQDA Crossed Above 200 DMA Bullish
2020-01-17 LQDA Stochastic Reached Overbought Strength
2020-01-17 LQDA Parabolic Rise Strength
2020-01-17 PFE Upper Bollinger Band Walk Strength
2020-01-17 PFE NR7 Range Contraction
2020-01-17 PHAS Fell Below 20 DMA Bearish
2020-01-17 PHAS Calm After Storm Range Contraction
2020-01-17 PSTI Calm After Storm Range Contraction
2020-01-17 RETA Bearish Engulfing Bearish
2020-01-17 RETA Bollinger Band Squeeze Range Contraction
2020-01-17 UTHR Upper Bollinger Band Walk Strength

Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure within the arteries of the lungs. Symptoms include shortness of breath, syncope, tiredness, chest pain, swelling of the legs, and a fast heartbeat. The condition may make it difficult to exercise. Onset is typically gradual.The cause is often unknown. Risk factors include a family history, prior blood clots in the lungs, HIV/AIDS, sickle cell disease, cocaine use, COPD, sleep apnea, living at high altitudes, and problems with the mitral valve. The underlying mechanism typically involves inflammation of the arteries in the lungs. Diagnosis involves first ruling out other potential causes.There is no cure. Treatment depends on the type of disease. A number of supportive measures such as oxygen therapy, diuretics, and medications to inhibit clotting may be used. Medications specifically for the condition include epoprostenol, treprostinil, iloprost, bosentan, ambrisentan, macitentan, and sildenafil. A lung transplant may be an option in certain cases.While the exact frequency of the condition is unknown, it is estimated that about 1,000 new cases occur a year in the United States. Females are more often affected than males. Onset is typically between 20 and 60 years of age. It was first identified by Ernst von Romberg in 1891.

More about Pulmonary Arterial Hypertension